Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE5026 extended prophylaxis after hip fracture surgery
2007-007947-28Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) comparing AVE5026 extended prophylaxis with Placebo (2 arms). Primary endpoint: Composite of venous thromboembolism and all-cause death. Started May 2008; status: completed.
02
Drugs
semuloparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2007-007947-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007947-28.